Abstract:Introduction: A major requirement in bone tissue engineering is the persistent and robust promotion of osteogenesis, which requires sustained stimulation with osteoinductive factors, such as bone morphogenetic protein-2 (BMP-2). However, the direct application of these factors remains challenging due to their short half-life and rapid systemic clearance. Given the well demonstrated benefits of recombinant adeno-associated viral (rAAV) vector, including long-term gene transfer efficiency and relative safety, rAAV-based therapies have been developed in both basic and translational research. However, traditional ex vivo gene transduction process is time consuming and requires multiple steps of cell culture. In addition, rAAV shows inconsistent transfection efficacy in primary cells. In this study, we co-packed rAAV-BMP-2 and human bone marrow stem cells (hBMSCs) into a gelatin scaffolds through one-step visible light-based phtocorsslinking (PXL), and tested their application for bone regenerationi. We hypothesize that the concentrated and localized release of rAAV-BMP-2 from the scaffold matrix results in higher transfection efficacy and BMP-2 expression in hBMSCs seeded within the scaffolds, thus enhancing their osteogenic differentiation and bone formation upon implantation in bone defect. Methods: hBMSCs were obtained with IRB approval from total joint arthroplasty patient. The rAAV6-BMP-2 and rAAV6-GFP reporter (as control) vectors were designed and prepared using an established protocol in our laboratory. PXL was performed using 10% gelatin and 10×106 hBMSCs/ml with different amount of rAAV6-GFP. Transfection efficiency was determined by counting GFP-positive cells ratio as well as assessing cell viability. At an optimal ratio, rAAV-BMP-2 and hBMSCs were included into gelatin through PXL. At different time point, BMP-2 production and rAAV6 release kinetics were analyzed. The osteogenesis of hBMSCs was assessed at day 28 by real time PCR and histological staining. In animal study, a 0.5 cm diameter critical size of cranial bone defect model was generated in SCID mice and then the constructs described above were transplanted. Micro-CT imaging and histological staining were used to evaluate the skull bone healing process up to 6 weeks. Results: Both rAAV and hBMSCs survived during the scaffold fabrication process. 10×104 rAAV/hBMSCs was shown to be the optimal ratio in maintaining cell viability and achieving transduction efficiency. After in situ transfection within scaffolds, hBMSCs produced higher BMP-2 amount than those subjected to traditional ex vivo transduction process, and underwent robust osteogenesis as well. In animal study, micro-CT imaging results indicated that rAAV BMP-2 & hBMSCs-activated gelatin scaffolds effectively promoted bone regeneration in mice cranial bone defect, in a manner significantly superior to that of scaffolds loaded with hBMSCs/BMP-2 protein, and was remarkably compatible to scaffolds loaded with hBMSCs previously ex vivo transduced by rAAV-BMP-2. The histological staining further confirmed the efficacious bone formation from rAAV BMP-2 & hBMSCs loaded scaffold. The results shown here thus demonstrate the feasibility of combining gene and cell therapy with biomaterial engineering via a single-step fabrication and its application for the repair of bone defect.

Combining "waste utilization" and "tissue to tissue" strategies to accelerate vascularization for bone repair

Preclinical Optimization of a Shelf-Ready, Injectable, Human-Derived, Decellularized Allograft Adipose Matrix.

Vascular Derived ECM Improves Therapeutic Index of BMP-2 and Drives Vascularized Bone Regeneration.

[Impact of Adipose-Derived Stem Cells Combined with Vascular Bundle Implantation on Vascularized Tissue Engineering Scaffolds in Vivo].

Time-Phase Sequential Utilization of Adipose-Derived Mesenchymal Stem Cells on Mesoporous Bioactive Glass for Restoration of Critical Size Bone Defects

Endothelialized microvessels fabricated by microfluidics facilitate osteogenic differentiation and promote bone repair

Innovative Regenerative Strategy for Reconstructing Breast Defect: Gas-foamed Gelatin Methacryloyl Scaffolds Combined with Human Adipose-Derived Stem Cell Spheroids

Angiogenic and Osteogenic Potential of Platelet-Rich Plasma and Adipose-Derived Stem Cell Laden Alginate Microspheres

Prefabrication of vascularized grafts based on pre-differentiated adipose derived stem cells, fibrin sealant and porous calcium phosphate cement scaffold

Prefabrication of Axially Vascularized Bone by Combining Β-Tricalciumphosphate, Arteriovenous Loop, and Cell Sheet Technique

524. Injectable BMP-2 Gene-Activated Scaffold for the Repair of Mouse Cranial Bone Defect

The Adjuvant Use Of Stromal Vascular Fraction And Platelet-Rich Fibrin For Autologous Adipose Tissue Transplantation

Adenovirus-mediated Transfer of VEGF into Marrow Stromal Cells Combined with PLGA/TCP Scaffold Increases Vascularization and Promotes Bone Repair in Vivo.

A Novel Strategy of Spine Defect Repair with a Degradable Bioactive Scaffold Preloaded with Adipose-Derived Stromal Cells.

Adipose-derived stem cells modified genetically in vivo promote reconstruction of bone defects.

Biomimetic vascularized adipose-derived mesenchymal stem cells bone-periosteum graft enhances angiogenesis and osteogenesis in a male rabbit spine fusion model

In Vitro Osteogenic Induction of Bone Marrow Mesenchymal Stem Cells with A Decellularized Matrix Derived from Human Adipose Stem Cells and in Vivo Implantation for Bone Regeneration

Exosomal mRNAs for Angiogenic–Osteogenic Coupled Bone Repair

Transfect Bone Marrow Stromal Cells with Pcdna3.1-Vegf to Construct Tissue Engineered Bone in Defect Repair

VEGF-Loaded Heparinised Gelatine-Hydroxyapatite-Tricalcium Phosphate Scaffold Accelerates Bone Regeneration via Enhancing Osteogenesis-Angiogenesis Coupling

In Situ Release of VEGF Enhances Osteogenesis in 3D Porous Scaffolds Engineered with Osterix-Modified Adipose-Derived Stem Cells.